An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening population.
OBJECTIVE
To investigate the prevalence of ATPIII- and IDF-defined metabolic syndrome (MetS) in an Irish screening population and to determine the calculated cardiovascular risk for each group.


METHODS
A total of 1,716 subjects were enrolled over a 12-month period.


RESULTS
The ATPIII-defined prevalence of MetS in this population was 13.2%. Using IDF criteria, 21.4% of subjects were identified as having the MetS. Correlation between the two definitions was high; however, IDF criteria identified an additional 9.5% (n = 164) of the population as having MetS, which ATPIII criteria failed to recognise.


CONCLUSIONS
We noted a higher prevalence of MetS in the studied population when defined by IDF criteria. However, those identified by IDF and not by ATPIII definition did not have a higher cardiovascular risk score by either Framingham or European Score than those without MetS. Thus, application of the ATPIII definition of MetS, may be the more practical.
Waterhouse
D F
DF
Department of Endocrinology and Metabolism, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland. Deirdrewaterhouse@ireland.com
McLaughlin
A M
AM
Sheehan
F
F
O'Shea
D
D
D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D005260:Female; D006305:Health Status Indicators; D006801:Humans; D007494:Ireland / Q000453:epidemiology; D008297:Male; D008403:Mass Screening; D024821:Metabolic Syndrome / Q000139:chemically induced / Q000453:epidemiology*; D008875:Middle Aged; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors; D013223:Statistics as Topic; D011795:Surveys and Questionnaires